BOUT
Innovator IBD Breakout Opportunities ETF
The innovator IBD Breakout Opportunities ETF tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors. The fund may hold 50% T-bills based on technical market signals.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 15.4 M
ASSETS UNDER MGMT
81 bp
EXPENSES
Fund Basics
| Inception date | Sep 12, 2018 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| CAREER EDUCATION CORP | 8.1 % |
| MAPLIGHT THERAPEUTICS INC | 6.9 % |
| SANDISK CORP | 6.7 % |
| VERADERMICS INC | 5.9 % |
| SOLV ENERGY INC | 5.9 % |
| CITIZENS FINANCIAL GROUP, INC. | 5.8 % |
| GOLAR LNG LTD | 5.3 % |
| KAISER ALUMINUM CORP | 5.1 % |
| ARROWHEAD PHARMACEUTICALS, INC. | 5.0 % |
| BRIDGE BANCORP INC | 5.0 % |
Constituent Breakdown
| Number of holdings | 31 |
| Herfindahl-Hirschman Index | 492 |
| Wgt avg mkt cap (mns) | $302,179 |
| Large cap (>$10bn) | 37.0% |
| Mid cap ($2-10bn) | 35.2% |
| Small cap (<$2bn) | 15.3% |
| Developed mkts. | 91.3% |
| Emerging mkts. | 0.5% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 80.6 % |
 |
BERMUDA | 5.3 % |
 |
BRITAIN | 4.8 % |
 |
CANADA | 0.6 % |
 |
CHILE | 0.5 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 8.2% | 8.3% | 4.0% | 8.0% | 3.5% | -- | -- | 6.3% |
| Dividend Yield | 0.0% | 0.0% | 0.3% | 0.7% | 0.7% | -- | -- | 0.5% |
| Total Returns | 8.2% | 8.3% | 4.3% | 8.7% | 4.2% | -- | -- | 6.8% | Ann. Volatility | 25.6% | 21.8% | 20.3% | 18.6% | 19.6% | -- | -- | 23.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.78 | 46% |
| MSCI EAFE | 0.83 | 45% |
| MSCI Emg Mkts | 0.76 | 49% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.6% |
| Avg. Bid/Ask (% of price) | 0.41% |
Technical Indicators
| 30d moving avg. (EMA) | $40.87 |
| Relative strength (RSI) | 64 |
| MACD/Signal | 1.07/0.70 |
| Bollinger Bands (Upper/Lower) | $44.28/$37.40 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. BOUT |
Expenses vs. BOUT |
ALTAR Score™ vs. BOUT |
|---|
Risk and Returns: BOUT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/21/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.0%
ALTAR SCORE™
24th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. BOUT's ALTAR Score™ is approximately -0.7 standard
deviations above the category average. This places BOUT in the 24th percentile
among funds in the category.
Sell-Side Consensus
$41.87
PRICE TARGET
-4.9%
UPSIDE